Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.

Identifieur interne : 001092 ( Main/Exploration ); précédent : 001091; suivant : 001093

Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.

Auteurs : Brian K. Mcfarlin [États-Unis] ; Katie C. Carpenter ; Tiffany Davidson ; Meredith A. Mcfarlin

Source :

RBID : pubmed:23927572

Descripteurs français

English descriptors

Abstract

Strenuous exercise, such as running a marathon, is known to suppress mucosal immunity for up to 24 hr, which can increase the risk of developing an upper respiratory tract infection (URTI) and reduced performance capacity (Allgrove JE, Geneen L, Latif S, Gleeson M. Influence of a fed or fasted state on the s-IgA response to prolonged cycling in active men and women. Int J Sport Nutr Exerc Metab. 2009;19(3):209-221; Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, Stauffacher EA. The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract. 2002;51(3):265; Carpenter KC, Breslin WL, Davidson T, Adams A, McFarlin BK. Baker's yeast beta glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Br J Nutr. 2012;1-9). While many dietary interventions have been used to combat postexercise immune suppression, most have been ineffective. The key purpose of this study was to determine if baker's yeast β-glucan (BG) could positively affect the immune system of individuals undergoing intense exercise stress using two experiments. In the first (E1; N = 182 men and women), BG was compared to placebo supplementation for the incidence of URTI symptoms for 28 days postmarathon. In the second (E2; N = 60 men and women) changes in salivary immunoglobulin A (IgA) were evaluated after 50-min of strenuous cycling when participants had been supplemented for 10 days with either BG (250 mg/day) or placebo (rice flour). For E1, subjects reported URTI symptoms using a daily health log. For E2, saliva was collected prior to, immediately, and 2-hr postexercise using a salivette. Data for E1 and E2 were analyzed using separate analyses of variance (ANOVAs) with repeated measures (p < .05). In E1, BG was associated with a 37% reduction in the number of cold/flu symptom days postmarathon compared to placebo (p = .026). In E2, BG was associated with a 32% increase in salivary IgA (p = .048) at 2 hr after exercise compared to placebo. In summary, the present study demonstrates that BG may reduce URTI symptomatic days and improve mucosal immunity (salivary IgA) postexercise.

DOI: 10.3109/19390211.2013.820248
PubMed: 23927572


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.</title>
<author>
<name sortKey="Mcfarlin, Brian K" sort="Mcfarlin, Brian K" uniqKey="Mcfarlin B" first="Brian K" last="Mcfarlin">Brian K. Mcfarlin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Applied Physiology Laboratory, Department of Kinesiology, Health Promotion, and Recreation, College of Education, University of North Texas, Denton, Texas 76203, USA. brian.mcfarlin@unt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Applied Physiology Laboratory, Department of Kinesiology, Health Promotion, and Recreation, College of Education, University of North Texas, Denton, Texas 76203</wicri:regionArea>
<wicri:noRegion>Texas 76203</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carpenter, Katie C" sort="Carpenter, Katie C" uniqKey="Carpenter K" first="Katie C" last="Carpenter">Katie C. Carpenter</name>
</author>
<author>
<name sortKey="Davidson, Tiffany" sort="Davidson, Tiffany" uniqKey="Davidson T" first="Tiffany" last="Davidson">Tiffany Davidson</name>
</author>
<author>
<name sortKey="Mcfarlin, Meredith A" sort="Mcfarlin, Meredith A" uniqKey="Mcfarlin M" first="Meredith A" last="Mcfarlin">Meredith A. Mcfarlin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23927572</idno>
<idno type="pmid">23927572</idno>
<idno type="doi">10.3109/19390211.2013.820248</idno>
<idno type="wicri:Area/PubMed/Corpus">000512</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000512</idno>
<idno type="wicri:Area/PubMed/Curation">000510</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000510</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000536</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000536</idno>
<idno type="wicri:Area/Ncbi/Merge">000594</idno>
<idno type="wicri:Area/Ncbi/Curation">000594</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000594</idno>
<idno type="wicri:Area/Main/Merge">001093</idno>
<idno type="wicri:Area/Main/Curation">001092</idno>
<idno type="wicri:Area/Main/Exploration">001092</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.</title>
<author>
<name sortKey="Mcfarlin, Brian K" sort="Mcfarlin, Brian K" uniqKey="Mcfarlin B" first="Brian K" last="Mcfarlin">Brian K. Mcfarlin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Applied Physiology Laboratory, Department of Kinesiology, Health Promotion, and Recreation, College of Education, University of North Texas, Denton, Texas 76203, USA. brian.mcfarlin@unt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Applied Physiology Laboratory, Department of Kinesiology, Health Promotion, and Recreation, College of Education, University of North Texas, Denton, Texas 76203</wicri:regionArea>
<wicri:noRegion>Texas 76203</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carpenter, Katie C" sort="Carpenter, Katie C" uniqKey="Carpenter K" first="Katie C" last="Carpenter">Katie C. Carpenter</name>
</author>
<author>
<name sortKey="Davidson, Tiffany" sort="Davidson, Tiffany" uniqKey="Davidson T" first="Tiffany" last="Davidson">Tiffany Davidson</name>
</author>
<author>
<name sortKey="Mcfarlin, Meredith A" sort="Mcfarlin, Meredith A" uniqKey="Mcfarlin M" first="Meredith A" last="Mcfarlin">Meredith A. Mcfarlin</name>
</author>
</analytic>
<series>
<title level="j">Journal of dietary supplements</title>
<idno type="eISSN">1939-022X</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Analysis of Variance</term>
<term>Bicycling (physiology)</term>
<term>Common Cold (complications)</term>
<term>Common Cold (drug therapy)</term>
<term>Common Cold (immunology)</term>
<term>Common Cold (metabolism)</term>
<term>Dietary Supplements</term>
<term>Exercise (physiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Immune System (drug effects)</term>
<term>Immunity (drug effects)</term>
<term>Immunoglobulin A (metabolism)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (metabolism)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Mucous Membrane (drug effects)</term>
<term>Mucous Membrane (immunology)</term>
<term>Mucous Membrane (metabolism)</term>
<term>Physical Exertion (physiology)</term>
<term>Running (physiology)</term>
<term>Saccharomyces cerevisiae (chemistry)</term>
<term>Saliva (immunology)</term>
<term>Saliva (metabolism)</term>
<term>Stress, Physiological (immunology)</term>
<term>Young Adult</term>
<term>beta-Glucans (pharmacology)</term>
<term>beta-Glucans (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de variance</term>
<term>Compléments alimentaires</term>
<term>Course à pied (physiologie)</term>
<term>Cyclisme (physiologie)</term>
<term>Effort physique (physiologie)</term>
<term>Exercice physique (physiologie)</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (métabolisme)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Humains</term>
<term>Immunité ()</term>
<term>Immunoglobuline A (métabolisme)</term>
<term>Jeune adulte</term>
<term>Muqueuse ()</term>
<term>Muqueuse (immunologie)</term>
<term>Muqueuse (métabolisme)</term>
<term>Mâle</term>
<term>Rhume banal ()</term>
<term>Rhume banal (immunologie)</term>
<term>Rhume banal (métabolisme)</term>
<term>Rhume banal (traitement médicamenteux)</term>
<term>Saccharomyces cerevisiae ()</term>
<term>Salive (immunologie)</term>
<term>Salive (métabolisme)</term>
<term>Stress physiologique (immunologie)</term>
<term>Système immunitaire ()</term>
<term>bêta-Glucanes (pharmacologie)</term>
<term>bêta-Glucanes (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Immunoglobulin A</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Common Cold</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Immune System</term>
<term>Immunity</term>
<term>Mucous Membrane</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Common Cold</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Muqueuse</term>
<term>Rhume banal</term>
<term>Salive</term>
<term>Stress physiologique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Common Cold</term>
<term>Influenza, Human</term>
<term>Mucous Membrane</term>
<term>Saliva</term>
<term>Stress, Physiological</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Common Cold</term>
<term>Influenza, Human</term>
<term>Mucous Membrane</term>
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Grippe humaine</term>
<term>Immunoglobuline A</term>
<term>Muqueuse</term>
<term>Rhume banal</term>
<term>Salive</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>bêta-Glucanes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>beta-Glucans</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Course à pied</term>
<term>Cyclisme</term>
<term>Effort physique</term>
<term>Exercice physique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Bicycling</term>
<term>Exercise</term>
<term>Physical Exertion</term>
<term>Running</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>beta-Glucans</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Grippe humaine</term>
<term>Rhume banal</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>bêta-Glucanes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Analysis of Variance</term>
<term>Dietary Supplements</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de variance</term>
<term>Compléments alimentaires</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Immunité</term>
<term>Jeune adulte</term>
<term>Muqueuse</term>
<term>Mâle</term>
<term>Rhume banal</term>
<term>Saccharomyces cerevisiae</term>
<term>Système immunitaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Strenuous exercise, such as running a marathon, is known to suppress mucosal immunity for up to 24 hr, which can increase the risk of developing an upper respiratory tract infection (URTI) and reduced performance capacity (Allgrove JE, Geneen L, Latif S, Gleeson M. Influence of a fed or fasted state on the s-IgA response to prolonged cycling in active men and women. Int J Sport Nutr Exerc Metab. 2009;19(3):209-221; Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, Stauffacher EA. The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract. 2002;51(3):265; Carpenter KC, Breslin WL, Davidson T, Adams A, McFarlin BK. Baker's yeast beta glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Br J Nutr. 2012;1-9). While many dietary interventions have been used to combat postexercise immune suppression, most have been ineffective. The key purpose of this study was to determine if baker's yeast β-glucan (BG) could positively affect the immune system of individuals undergoing intense exercise stress using two experiments. In the first (E1; N = 182 men and women), BG was compared to placebo supplementation for the incidence of URTI symptoms for 28 days postmarathon. In the second (E2; N = 60 men and women) changes in salivary immunoglobulin A (IgA) were evaluated after 50-min of strenuous cycling when participants had been supplemented for 10 days with either BG (250 mg/day) or placebo (rice flour). For E1, subjects reported URTI symptoms using a daily health log. For E2, saliva was collected prior to, immediately, and 2-hr postexercise using a salivette. Data for E1 and E2 were analyzed using separate analyses of variance (ANOVAs) with repeated measures (p < .05). In E1, BG was associated with a 37% reduction in the number of cold/flu symptom days postmarathon compared to placebo (p = .026). In E2, BG was associated with a 32% increase in salivary IgA (p = .048) at 2 hr after exercise compared to placebo. In summary, the present study demonstrates that BG may reduce URTI symptomatic days and improve mucosal immunity (salivary IgA) postexercise.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Carpenter, Katie C" sort="Carpenter, Katie C" uniqKey="Carpenter K" first="Katie C" last="Carpenter">Katie C. Carpenter</name>
<name sortKey="Davidson, Tiffany" sort="Davidson, Tiffany" uniqKey="Davidson T" first="Tiffany" last="Davidson">Tiffany Davidson</name>
<name sortKey="Mcfarlin, Meredith A" sort="Mcfarlin, Meredith A" uniqKey="Mcfarlin M" first="Meredith A" last="Mcfarlin">Meredith A. Mcfarlin</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Mcfarlin, Brian K" sort="Mcfarlin, Brian K" uniqKey="Mcfarlin B" first="Brian K" last="Mcfarlin">Brian K. Mcfarlin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001092 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001092 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23927572
   |texte=   Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23927572" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021